453 results on '"Grimison, Peter"'
Search Results
2. Association between low total serum testosterone and body mass index in Australian survivors of testicular cancer: a retrospective analysis
3. Correction to: Using three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionals
4. Sleep dysfunction associated with worse chemotherapy-induced peripheral neurotoxicity functional outcomes
5. First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors
6. Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
7. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium
8. Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial
9. High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party
10. Upper-limb dysfunction in cancer survivors with chemotherapy-induced peripheral neurotoxicity
11. A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand sarcoma association clinical practice guidelines working party
12. Robotic-assisted retroperitoneal lymph node dissection for stage II testicular cancer
13. Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients
14. Using three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionals
15. Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy
16. SPARC – A multi‐disciplinary team program for retroperitoneal sarcoma: the Royal Prince Alfred Hospital and Chris O'Brien Lifehouse Collaboration
17. Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCT
18. Psychosocial well-being and supportive care needs of cancer patients and survivors living in rural or regional areas: a systematic review from 2010 to 2021
19. Staff perspectives on the feasibility of a clinical pathway for anxiety and depression in cancer care, and mid-implementation adaptations
20. Development, acceptability and uptake of an on-line communication skills education program targeting challenging conversations for oncology health professionals related to identifying and responding to anxiety and depression
21. Metastatic Non‐Myofibroblastic Sarcoma Harbouring EML4‐ALK Fusion—Dramatic Response to ALK Tyrosine Kinase Inhibitors and Development of Resistance Mutations.
22. Estimating survival scenarios in advanced or metastatic gastric and oesophageal adenocarcinoma: a systematic review of randomized-controlled trials.
23. A case for the use of chemotherapy in hereditary mitochondrial optic neuropathies: Successful administration of cisplatin/etoposide in a male patient with testicular seminoma and Leber's hereditary optic neuropathy.
24. Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia
25. Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity
26. Abstract C011: Detection of circulating tumor cells for the early detection of pancreatic cancer
27. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN)
28. Impact of Teratoma on Survival Probabilities of Patients with Metastatic Non-Seminomatous Germ Cell Cancer
29. Patient-reported outcome measures and supportive care need assessment in patients attending an Australian comprehensive care centre: a multi-method study
30. A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours
31. Fidelity and acceptability of implementation strategies developed for adherence to a clinical pathway for screening, assessment and management of anxiety and depression in adults with cancer.
32. Estimating survival time in older adults receiving chemotherapy for advanced cancer
33. A case for the use of chemotherapy in hereditary optic neuropathies: successful administration of cisplatin/etoposide in a male patient with testicular seminoma and Leber’s Hereditary Optic Neuropathy
34. Accuracy of oncologists’ estimates of expected survival time in advanced cancer
35. A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand Sarcoma Association clinical practice guidelines working party
36. Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations
37. Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease
38. Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report
39. The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer
40. Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy
41. Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement
42. Patient satisfaction with telehealth consultations in medical oncology clinics: A cross-sectional study at a metropolitan centre during the COVID-19 pandemic.
43. United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument.
44. Prognostic value of patient reported outcomes in advanced gastro‐oesophageal cancer: a systematic review
45. Association of chemotherapy dose intensity and age with outcomes in patients with Ewing's family sarcoma
46. Quantitative proteomic studies addressing unmet clinical needs in sarcoma
47. Online psychological self-management intervention for testicular cancer survivors (e-TC 2.0): promising acceptability and preliminary efficacy, but limited feasibility
48. Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer
49. Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging
50. Trial in progress: PRESTIGE—Primary retroperitoneal lymph node dissection (RPLND) for clinical stage II (CSII) testicular germ cell tumour (TGCT) and its impact on health-related quality of life (HRQoL) compared to chemotherapy or radiotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.